Back to top
more

Anthem, Inc. (ANTM)

(Delayed Data from NYSE)

$261.70 USD

261.70
1,184,666

+0.11 (0.04%)

Updated May 3, 2019 04:00 PM ET

After-Market: $261.69 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Cigna (CI) Q4 Earnings Beat on Robust Cigna Healthcare Unit

by Zacks Equity Research

Cigna's (CI) fourth-quarter results benefit from strong medical customer growth. A solid outlook for 2022 when compared to the 2021 level remains noteworthy.

The Zacks Analyst Blog Highlights: Chevron Corp., HSBC Holdings plc, and Anthem, Inc

by Zacks Equity Research

Chevron Corp., HSBC Holdings plc, and Anthem, Inc are highlighted in this Analyst Blog article.

Mark Vickery headshot

Top Research Reports for Chevron, HSBC & Anthem

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), HSBC Holdings plc (HSBC), and Anthem, Inc. (ANTM).

Encompass Health's (EHC) Q4 Earnings Miss Mark, Increase Y/Y

by Zacks Equity Research

Encompass Health's (EHC) Q4 results reflect escalating costs, partly offset by higher revenues, courtesy of its Inpatient Rehabilitation segment.

Cigna's (CI) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Cigna's (CI) fourth-quarter earnings results likely to reflect higher revenues and solid segmental contributions.

HCA Healthcare's (HCA) Q4 Earnings Miss Mark, Improve Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) Q4 results reflect higher expenses, partly offset by better revenues owing to improved patient volumes.

Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y

by Zacks Equity Research

Anthem's (ANTM) Q4 results reflect better revenues and a solid contribution from its Government Business and IngenioRx businesses, partly offset by escalating expenses.

Anthem (ANTM) Q4 Earnings Top Estimates

by Zacks Equity Research

Anthem (ANTM) delivered earnings and revenue surprises of 0.59% and 0.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Anthem (ANTM) Gears Up for Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Anthem's (ANTM) fourth-quarter results are likely to reflect gains from increased premiums and strong membership growth across its Medicare and Medicaid businesses, partly offset by rising expenses.

The Zacks Analyst Blog Highlights: Roche Holding AG, Anthem, Inc. and Infosys Limited

by Zacks Equity Research

Roche Holding AG, Anthem, Inc. and Infosys Limited are highlighted ikn this Analyst Blog article.

Anthem (ANTM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Anthem (ANTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sheraz Mian headshot

Top Research Reports for Roche, Anthem & Infosys

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Anthem, Inc. (ANTM), and Infosys Limited (INFY).

Humana (HUM) to Buy Back Shares of $1B to Add Shareholder Value

by Zacks Equity Research

Humana (HUM) to buy back shares worth $1 billion as part of its $3-billion share repurchase plan announced in February 2021. This suggests its commitment toward delivering a long-term shareholder value.

Why Holding Anthem (ANTM) in Your Portfolio is a Prudent Move?

by Zacks Equity Research

Riding high on its strategic measures and a rising membership, Anthem (ANTM) holds prospects to reap benefits for investors.

    Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?

    by Zacks Equity Research

    Sector ETF report for RYH

    Molina Healthcare (MOH) Buys Cigna's TX Medicaid Contracts

    by Zacks Equity Research

    Molina Healthcare (MOH) purchases the Texas Medicaid contracts of Cigna to bolster its presence in the Texas region.

    Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

    by Zacks Equity Research

    Sector ETF report for IHF

    Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for RYH

    Centene (CNC) Receives DMHC Approval for Magellan Acquisition

    by Zacks Equity Research

    Centene's (CNC) acquisition with Magellan Health is likely to close on Jan 4, 2022, around a year after the deal announcement.

    Zacks Investment Ideas feature highlights: Anthem, UnitedHealth Group and Molina Healthcare

    by Zacks Equity Research

    Zacks Investment Ideas feature highlights: Anthem, UnitedHealth Group and Molina Healthcare

    Centene vs. Anthem: Which is a Better-Positioned Stock?

    by Zacks Equity Research

    Centene (CNC) and Anthem (ANTM) are poised to grow in the prospering health insurance industry. On comparative evaluation, we try to discover which stock is more profitable, based on the fundamentals.

    Bryan Hayes headshot

    Neutralize Higher Health Insurance Premiums In 2022

    by Bryan Hayes

    Buy These Health Providers to Counteract Bigger Health Insurance Premiums

    Kaibalya Pravo Dey headshot

    4 Health Insurers Poised to Maintain Winning Streak in 2022

    by Kaibalya Pravo Dey

    Buoyed by government support and technological improvements, stocks in the health insurance industry are likely to witness increased product demand. UNH, ANTM, CNC & MOH are well positioned to make the most of the market improvement.

    The Zacks Analyst Blog Highlights: Adobe, Raytheon, Anthem, Palo Alto Networks and Roper Tech

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: Adobe, Raytheon, Anthem, Palo Alto Networks and Roper Tech

    Mark Vickery headshot

    Top Analyst Reports for Adobe, Raytheon & Anthem

    by Mark Vickery

    Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Raytheon Technologies Corporation (RTX), and Anthem, Inc. (ANTM).